Press Releases on January 9, 2023 - EIN Presswire - Press Release Distribution Service

Published on January 9, 2023 - 13:00 GMT

Saffron Market is Predicted to Expand at a rate of 8.1% by 2027 | IndustryARC

Rising cosmetic demand and augmenting health complications are expected to boost the market growth. HYDERABAD, TELANGANA, INDIA, January 9, 2023 /⁨EINPresswire.com⁩/ -- IndustryARC, in its latest report, predicts that The Saffron Market size is …

Distribution channels: Food & Beverage Industry ...

Published on January 9, 2023 - 13:00 GMT

Helsinn announces the appointment of Dr Melanie Rolli as Group Chief Executive Officer

Helsinn announces the appointment of Dr Melanie Rolli as Group Chief Executive Officer - Giorgio Calderari appointed Vice Chairman of the Board Lugano, Switzerland, January 9, 2023 - Helsinn Group (“Helsinn”), a fully integrated, global biopharma company …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 9, 2023 - 13:00 GMT

STMicroelectronics Announces Status of Common Share Repurchase Program

STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from Jan 03, 2023 to Jan 06, 2023 AMSTERDAM – January 9, 2023 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a …

Distribution channels: Media, Advertising & PR, Technology ...

Published on January 9, 2023 - 13:00 GMT

Beyond Technology Partners with Infinera to Successfully Deploy Multi-terabit Network to Support Bandwidth Demand During FIFA ...

DOHA, Qatar, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Beyond Technology, a global player in technology transformation, and Infinera successfully deployed a 3.6-terabit network for a leading Middle East network operator to support the upsurge in global and local …

Distribution channels: Companies, Media, Advertising & PR ...

Published on January 9, 2023 - 13:00 GMT

Nova Vision Acquisition Corp. Announces Extension of Combination Period and Additional Contribution to Trust Account to Extend ...

Singapore, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Nova Vision Acquisition Corp. (NASDAQ: NOVV, the “Company”), a special purpose acquisition company, announced today that Nova Pulsar Holdings Limited, the Company’s initial public offering sponsor (“Sponsor”), …

Distribution channels: Banking, Finance & Investment Industry

Published on January 9, 2023 - 13:00 GMT

UAV CORP’S SKYBORNE TECHNOLOGY RECEIVES PERMIT APPROVAL FROM GULF COUNTY, FLORIDA FOR THE BUILD OF A NEW DRONE HANGAR

Port St. Joe-Wewahitchka, Florida, Jan. 09, 2023 (GLOBE NEWSWIRE) -- UAV Corp’s (OTC Pink: UMAV) Skyborne Technology receives building permit from Gulf County, Florida for the build of the largest drone hangar in the State of Florida. Further, from the …

Distribution channels:

Published on January 9, 2023 - 13:00 GMT

ENA Respiratory Awarded $4.38 Million U.S. Department of Defense Agreement to Fund Development of Broad-Spectrum Antiviral INNA-...

-- Goal is to add new medical countermeasure (MCM) against known and emerging viral respiratory threats MELBOURNE, Australia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Clinical-stage pharmaceutical company ENA Respiratory has been awarded a $4.38 million USD …

Distribution channels: Healthcare & Pharmaceuticals Industry, Politics ...

Published on January 9, 2023 - 13:00 GMT

Vencora Welcomes New Insurance Portfolio Manager and Banking COO to Executive Team

TORONTO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Vencora, a leading Financial Services acquirer and operator, today announced the appointments of Darren Klauser as Portfolio Manager, Insurance (PM) and Sue Sampson-Laws as Chief Operating Officer, Banking (COO). …

Distribution channels: Companies, Insurance Industry ...

Published on January 9, 2023 - 13:00 GMT

Navient to announce fourth quarter 2022 results on Jan. 24, host earnings webcast on Jan. 25

WILMINGTON, Del., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI), a leader in technology-enabled education finance and business processing solutions, plans to release its 2022 fourth quarter financial results on Navient.com/investors after market …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on January 9, 2023 - 13:00 GMT

VoIP-Pal Receives Favorable Claim Construction Ruling in its Patent Infringement Case Against Samsung

WACO, Texas, Jan. 09, 2023 (GLOBE NEWSWIRE) -- VoIP-Pal.com Inc. (“VoIP-Pal”, “Company”) (OTCQB: VPLM) is pleased to announce the Company has received a favorable result in the Claim Construction Hearing that was held on January 4, 2023, in the U.S. …

Distribution channels: Law, Telecommunications ...

Published on January 9, 2023 - 13:00 GMT

AmMax Bio Enters into an Exclusive Option Agreement with Evopoint Biosciences to License a Next Generation Antibody Drug Conjugate ...

This novel ADC is expected to have a wider therapeutic index and superior clinical profile across a broad range of solid tumors IND submission is planned for mid-2023 REDWOOD CITY, Calif. and SUZHOU, China, Jan. 09, 2023 (GLOBE NEWSWIRE) -- AmMax Bio, …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on January 9, 2023 - 13:00 GMT

authID Deploys Verified™ Human Factor Authentication™ Service with Tax Status

Verified™ stops account takeover with unphishable authentication for Tax Status’ enterprise partners DENVER, Jan. 09, 2023 (GLOBE NEWSWIRE) -- authID [Nasdaq: AUID], a leading provider of secure identity authentication solutions, today announced that Tax …

Distribution channels: IT Industry, Media, Advertising & PR ...

Published on January 9, 2023 - 13:00 GMT

SAB Biotherapeutics’ CMO Alexandra Kropotova to Deliver Presentation on Next Generation Biologics in Immunology at Biotech ...

SIOUX FALLS, S.D., Jan. 09, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, high-avidity, fully-human polyclonal …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on January 9, 2023 - 13:00 GMT

Clarity Updates on the Lithium381 Property

VANCOUVER, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Clarity Metals Corp. (“Clarity” or the “Company”) (CSE: CMET, OTC: CLGCF, FSE: 27G) is pleased to provide on update on exploration progress at the Lithium381 property (the “Property”) located …

Distribution channels:

Published on January 9, 2023 - 13:00 GMT

SIOS Reveals Technology Predictions for 2023

SAN MATEO, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- SIOS Technology Corp., an industry leader in application high availability (HA) and disaster recovery (DR), today announced top technology predictions for 2023. 2022 continued the pace of uncertainty as …

Distribution channels: Technology ...

Published on January 9, 2023 - 13:00 GMT

Saras Micro Devices Appoints Industry Leader Ron Huemoeller to CEO

ATLANTA, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The Board of Directors of Saras Micro Devices (SMD), a provider of advanced power delivery solutions for high-performance semiconductor devices, is pleased to announce the appointment of Ron Huemoeller as Chief …

Distribution channels: Companies, Technology ...

Published on January 9, 2023 - 13:00 GMT

Treace Medical Concepts Provides 2022 Preliminary Unaudited Revenue

PONTE VEDRA, Fla., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions) …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on January 9, 2023 - 13:00 GMT

Douglas Meyer Joins Bonaccord Capital Partners as Managing Director and Global Head of Strategic Development

NEW YORK, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Bonaccord Capital Partners, a private equity business focused on acquiring non-control equity interests in middle-market private markets sponsors, is pleased to announce that Doug Meyer has joined the firm as …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on January 9, 2023 - 13:00 GMT

Cerevance Announces Positive Topline Data from Phase 1 Clinical Trial of CVN766 for the Potential Use in the Treatment of ...

CVN766 was well tolerated with no serious adverse events CVN766, which has >1000-fold selectivity for the orexin 1 receptor, was well tolerated and showed no evidence of somnolence Data supports once a day dosing of CVN766 in future studies BOSTON, Jan. …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on January 9, 2023 - 13:00 GMT

Theriva Biologics Announces Dosing of First Patient in the Investigator Sponsored Phase 1 Trial of VCN-01, an Intravenous ...

-Clinical trial is being conducted at St. James’s University Hospital, United Kingdom, in collaboration with the University of Leeds- ROCKVILLE, Md., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a …

Distribution channels: Science, Technology ...